CD14 and rheumatoid arthritis: We have demonstrate that the absolute number of circulating monocytes and their CD14+highCD16− and CD14+highCD16+ subsets have a predictive value for the clinical response to methotrexate treatment in untreated rheumatoid arthritis patients with high sensitivity and specificity.